U.S. Wound Wash Market Size To Reach $8.90 billion By 2030

U.S. Wound Wash Market Growth & Trends

The U.S. wound wash market size is anticipated to reach USD 8.90 billion by 2030 and is anticipated to expand at a CAGR of 5.56% during the forecast period, according to a new report by Grand View Research, Inc. The U.S. wound wash market is experiencing significant growth due to the increasing number of surgical procedures, trauma cases, and the rising prevalence of chronic wounds such as diabetic ulcers and pressure sores. Traditional wound cleansing methods have evolved with advancements in antimicrobial agents, biofilm-disrupting solutions, and automated irrigation systems, making wound care more effective and efficient. The shift toward advanced antimicrobial solutions is one of the most essential factors driving the wound wash market.

New product launches and FDA approvals in the U.S. wound wash market drive significant wound and surgical wash advancements by promoting innovation, enhancing safety standards, and improving clinical outcomes. In June 2023, VeriCyn Wound Wash from Armis Biopharma obtained 510(k) clearance from the FDA, marking a significant advancement in wound care solutions. This regulatory approval enhances the credibility and adoption of the product, ensuring it meets safety and efficacy standards for wound debris removal. The approval also reflects ongoing technological advancements in wound and surgical washes, promoting the development of innovative, antimicrobial, and bioactive formulations. As demand for safe and effective wound cleansing solutions grows, such FDA approvals drive market expansion, improve patient outcomes, and encourage further innovations in the U.S. wound wash market.

Furthermore, the U.S. wound care market is significantly influenced by increased investments from military sectors and industry players through strategic collaborations and partnerships. These factors collectively drive innovation, enhance product development, and expand market reach, propelling growth. For instance, in January 2024, the U.S. Army has awarded Minnesota's 3M Company a USD 34.2-million contract to develop medical solutions for traumatic wounds, infection, and associated healing processes. These initiatives aim to enhance care for acute trauma cases such as blasts, burns, and gunshot wounds in military and civilian settings.

 Request a free sample copy or view report summary: U.S. Wound Wash Market Report

U.S. Wound Wash Market Report Highlights

• Based on product, the antiseptic segment dominate the market with the largest revenue share owing to their effectiveness in preventing infection, a primary concern in wound care.

• Based on product form, the solutions segment dominate the market with the largest revenue share owing to their versatility, ease of use, and ability to clean a wide range of wounds.

• Based on application, the acute wound segment dominate the market with the largest revenue share. Acute wounds, being more common and often requiring immediate care, drive the demand for wound wash products.

• Based on end-use, the hospitals dominated the market with the largest revenue share owing to their high volume of patients and diverse wound care needs. Hospitals are the largest consumers of wound wash products.

U.S. Wound Wash Market Segmentation

Grand View Research has segmented the U.S. wound wash market on the basis of product, application, type, end-use:

U.S. Wound Wash Product Outlook (Revenue, USD Million, 2018 - 2030)

• Antiseptic

• Povidone Iodine

• Chlorhexidine

• Polyhexanide (PHMB)

• Others

• Saline Solution

• Irrigation Solution

• Pulsed Lavage Systems

• Disposable

• Reusable

• Semi Disposable

• Others

U.S. Wound Wash Product Form Outlook (Revenue, USD Million, 2018 - 2030)

• Solutions

• Sprays

• Wipes

• Others

U.S. Wound Wash Application Outlook (Revenue, USD Million, 2018 - 2030)

• Acute Wounds

• Surgical & Traumatic Wounds

• Burns & Lacerations

• Chronic Wounds

• Diabetic Foot Ulcers

• Pressure Ulcers

• Venous Leg Ulcers

• Other Chronic Wounds

U.S. Wound Wash End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Specialty Clinics

• Ambulatory Surgery Centers

• Military & Defense

• Others

List of Key Players in the U.S. Wound Wash Market

• Atlantis Consumer Healthcare Inc.

• Medline Industries, LP

• B. Braun SE

• Johnson & Johnson Consumer Inc. (Johnson & Johnson)

• Zimmer Biomet

• Urgo Medical North America (URGO Group)

• Coloplast Corp (Coloplast Group)

• Mölnlycke Health Care AB

• Cardinal Health

• Armis Biopharma

• Bravida Medical

• Irrimax Corporation

• BD

• Sanara MedTech Inc.

• Pure&Clean

• Innovacyn, Inc.